Search Site
Menu
Sanofi-Aventis Earns $38 Million for Role in Blowing Whistle on Maker of EpiPens

Sanofi-Aventis, a large pharmaceutical company, was awarded $38.7 million for its role in bringing a $465 million False Claims Act case against Mylan. The company settled amid allegations that it knowingly misclassified EpiPen as a generic drug so it could avoid paying back the rebates it owed to Medicaid.

The lawsuit was initially filed under the whistleblower provisions of the False Claims Act. The FCA allows private parties to file lawsuits on behalf of the federal government, and then share in any money that is recovered due to the legal action. While whistleblowers in such cases are often private individuals, in this case the whistleblower was a pharmaceutical manufacturer. Sanofi-Aventis is a Paris-based company, but used its American unit to file the lawsuit.

The settlement agreement resolved the allegations that Mylan had wrongly reported EpiPen as a generic drug to the Medicaid office despite the absence of any equivalent drug on the market. In doing so, it could massively increase prices on the markets while avoiding Medicaid rebate obligations. Between 2010 and 2016, Mylan increased the price of its EpiPen by 400 percent, but continued to pay a fixed 13 percent rebate to Medicaid, despite knowing its drug was not a generic.

FCA claims can become quite lucrative

The federal government may choose to intervene in any False Claims Act suits brought forth by private parties. When it does, it is typically an indication that it believes the case has merit and significant value.

The government’s intervention on this specific issue reflected how focused the federal government is on fighting back against healthcare fraud, which regularly costs the government billions of dollars. The False Claims Act is a powerful anti-healthcare fraud tool.

For guidance on how to file a False Claims Act if you are aware of wrongdoing and the steps you should take next, work with a trusted whistleblower attorney at Whistleblower Law for Managers.

Honors
Our Office
  • Dallas Office
    4514 Cole Ave
    #600
    Dallas, Texas 75205
    Phone: 214-306-8045
    Fax: 469-729-9926
Testimonials
  • "Steve Kardell was terrific in representing me in some very adversarial discussions with Citigroup and also later represented me in my testimony before the Financial Crisis Inquiry Commission."  -Richard Bowen, Citigroup Whistleblower

  • "Never thought my career would end like it did after 30 years of service. I was part of the first round of the so called reduction of force. I asked myself how can I be part of this with 30 years of seniority. How did they pick these 90 plus employees? Now, the culture of this organization made you question every decision they made. It wasn’t what you knew it’s was a culture of who you know. Nonetheless, I did not accept their severance package. I immediately starting looking for an attorney who would take on my case. After the initial call to Steve I had hope again. He was open and honest about everything and reassured me he would do his best for me, and he did. I had an awesome outcome. Thanks Steve you’re the best."  -S.S.

  • "Reaching out to Steve Kardell was the best decision I made. His ability to provide immediate insight and direction was very powerful, and a huge relief during a very stressful time period. For anyone struggling with a whistleblower situation, I would highly recommend at least speaking with Steve. After a 10 minute call with him, I had a better understanding of what I was dealing with. Even better, he gave me some immediate hope. In the end Steve did a better job than I thought was possible. Steve was able to get in contact with people in my organization, that I didn’t have access to. Because of his years of experience, he already has contacts in many organizations in Dallas. The entire situation was handled peacefully. I was impressed by his ability to “keep the peace”–rather than creating a battle with the organization. The reason I didn’t reach out to a lawyer initially, was because I thought it would mean an immediate end to any hope of a positive relationship with the company. Steve was able to address my concerns, and in the end I was able to continue to work for them."  -KS

FOLLOW US
Facebook Twitter Linkedin RSS Feed JD Supra